KIMBERLY SELF: Open Payments
NPI 1932619236 · ARAB, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$665 in 33 payments from 10 companies in 2025. Trend: 2023 $1,257 · 2024 $1,103 · 2025 $665
Food & beverage: $665
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $210 |
| AstraZeneca Pharmaceuticals LP | 8 | $133 |
| PFIZER INC. | 4 | $78 |
| GlaxoSmithKline, LLC. | 3 | $62 |
| Exact Sciences Corporation | 3 | $53 |
| Ardelyx, Inc. | 2 | $41 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $27 |
| Vanda Pharmaceuticals Inc. | 1 | $25 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
Products named: VRAYLAR, NURTEC ODT, BREZTRI, TRELEGY ELLIPTA, IBSRELA, FARXIGA, Cologuard Collection Kit, Kerendia.
Industry payments across AL — which companies pay providers there.
